{
    "code": "60001155",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60001155",
    "time": "2022-10-28 03:56:30",
    "許可證字號": "衛部菌疫輸字第001155號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "115\/06\/17",
    "發證日期": "110\/06\/17",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA06000115500",
    "中文品名": "類希瑪 皮下注射液",
    "英文品名": "Remsima Solution for injection",
    "適應症": "類風濕性關節炎：\r\n與methotrexate併用，減緩中度到重度活動性疾病病人的徵兆及症狀，抑制結構性損傷的惡化，經HAQ-D1量表評估，可改善日常生活功能。",
    "劑型": "220皮下注射劑",
    "包裝": "120毫克預充填注射針筒裝 120毫克附自動針頭保護裝置預充填注射針筒裝 120毫克預充填注射筆裝，100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "基因工程產品_新使用途徑",
    "監視期限": "115\/06\/17",
    "主成分略述": "Infliximab",
    "限制項目": "02輸　入 1D須執行風險管理計畫",
    "申請商名稱": "620118P360  台灣賽特瑞恩有限公司",
    "申請商地址": "臺北市信義區松仁路97號3樓之1",
    "主製造廠": [
        {
            "製造廠名稱": "FDE0267600  VETTER PHARMA - FERTIGUNG GMBH &amp; CO. KG",
            "製造廠廠址": "SCHUTZENSTRABE 87 AND 99-101 88212 RAVENSBURG, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FDE0559000  VETTER PHARMA-FERTIGUNG GMBH &amp; CO KG",
            "製造廠廠址": "MOOSWIESEN 2, 88214 RAVENSBURG, GERMANY",
            "製造廠公司地址": "",
            "製造廠國別": "GERMANY",
            "製程": "預充式注射器包裝廠、附有自動針頭保護裝置之預充式注射器包裝廠"
        },
        {
            "製造廠名稱": "FKR0182000  CELLTRION INC.",
            "製造廠廠址": "23, ACADEMY-RO, YEONSU-GU, INCHEON, 22014, REPUBLIC OF KOREA",
            "製造廠公司地址": "",
            "製造廠國別": "KOREA",
            "製程": "原料藥廠、公司"
        },
        {
            "製造廠名稱": "MUS4907000  SHL Pharma LLC.",
            "製造廠廠址": "588 Jim Moran Boulevar, Deefield Beech, FL 33442,USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "預充式注射筆包裝廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9200081100",
            "成分名稱": "Infliximab",
            "含量描述": "",
            "含量": "120.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "CT-P13 SC 120mg_PFS-S_Leaflet_Taiwan_ver4(20220816)(Vetter)_ shelf life extension-111-08-16(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001155&Seq=004&Type=9"
        },
        {
            "title": "CT-P13 SC 120mg_PFS-S_Leaflet_Taiwan_ver2(400x805(135x40))(Vetter)_08Dec21-111-02-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001155&Seq=003&Type=9"
        },
        {
            "title": "CT-P13 SC 120mg_AI_Leaflet_Taiwan_ver4(400x805(40x135))(SHL)_08Dec21-111-02-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001155&Seq=002&Type=9"
        },
        {
            "title": "CT-P13 SC SmPC Extract_ remsima-epar-CN_0812 CLT_clean-110-10-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001155&Seq=001&Type=9"
        },
        {
            "title": "CT-P13 SC 120mg_AI_Carton 1P_Taiwan_ver5(SHL)_08Dec21-111-02-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001155&Seq=009&Type=8"
        },
        {
            "title": "CT-P13 SC 120mg_PFS-S_Carton 1P_Taiwan_ver12(Vetter)_08Dec21-111-02-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001155&Seq=008&Type=8"
        },
        {
            "title": "CT-P13 SC 120mg_PFS-S_label_Taiwan_ver1(Vetter)-110-10-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001155&Seq=007&Type=8"
        },
        {
            "title": "CT-P13 SC 120mg_PFS-S_Carton 1P_Taiwan_ver4(Vetter)-110-10-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001155&Seq=006&Type=8"
        },
        {
            "title": "CT-P13 SC 120mg_PFS_label_Taiwan_ver1(Vetter)-110-10-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001155&Seq=005&Type=8"
        },
        {
            "title": "CT-P13 SC 120mg_PFS_Carton 1P_Taiwan_ver4(Vetter)-110-10-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001155&Seq=004&Type=8"
        },
        {
            "title": "CT-P13 SC 120mg_AI_label_Taiwan_ver1(SHL)-110-10-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001155&Seq=003&Type=8"
        },
        {
            "title": "CT-P13 SC 120mg_AI_Carton 1P_Taiwan_ver4(Egis)-110-10-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001155&Seq=002&Type=8"
        },
        {
            "title": "CT-P13 SC 120mg_AI PFS PFS-S_PRC_Taiwan_ver5(135x40)(Vetter)-110-10-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60001155&Seq=001&Type=8"
        }
    ]
}